Afinitor Approved for Advanced Breast Cancer
FRIDAY, July 20 (Healthday News) -- Afinitor (everolimus) has been approved in combination with the drug exemestane to treat postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer, the U.S. Food and Drug Administration said Friday. read more..
source:http://yhoo.it/OM3q3V
No comments:
Post a Comment